These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8886506)

  • 21. Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension.
    Asmar RG; Pannier B; Santoni JP; Laurent S; London GM; Levy BI; Safar ME
    Circulation; 1988 Oct; 78(4):941-50. PubMed ID: 2971473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial perfusion during long-term angiotensin-converting enzyme inhibition or beta-blockade in patients with essential hypertension.
    Buus NH; Bøttcher M; Jørgensen CG; Christensen KL; Thygesen K; Nielsen TT; Mulvany MJ
    Hypertension; 2004 Oct; 44(4):465-70. PubMed ID: 15326083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin-converting enzyme inhibition and vascular structure in hypertension.
    Gibbons GH
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S19-24. PubMed ID: 1725196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormalities of the resistance vasculature in hypertension: correction by vasodilator therapy.
    Mulvany MJ
    Pharmacol Rep; 2005; 57 Suppl():144-50. PubMed ID: 16415495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular haemodynamic effects of perindopril in essential hypertension.
    Littler W
    Drugs; 1990; 39 Suppl 1():43-8. PubMed ID: 2407492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perindopril treatment affects both preglomerular renal vascular lumen dimensions and in vivo responsiveness to vasoconstrictors in spontaneously hypertensive rats.
    Bergström G; Johansson I; Stevenson KM; Kett MM; Anderson WP
    Hypertension; 1998 Apr; 31(4):1007-13. PubMed ID: 9535428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term.
    Harrap SB; Van der Merwe WM; Griffin SA; Macpherson F; Lever AF
    Hypertension; 1990 Dec; 16(6):603-14. PubMed ID: 2246027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of angiotensin-converting enzyme inhibitors on resistance artery structure and endothelium-dependent relaxation in two-kidney, one-clip Goldblatt hypertensive and sham-operated rats.
    Bennett MA; Thurston H
    Clin Sci (Lond); 1996 Jan; 90(1):21-9. PubMed ID: 8697701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin converting enzyme inhibition, pulse wave velocity and ambulatory blood pressure measurements in essential hypertension.
    Santoni JP; Asmar R; Safar ME
    Clin Exp Hypertens A; 1989; 11 Suppl 2():535-44. PubMed ID: 2691127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control of vascular changes by renin-angiotensin-aldosterone system in salt-sensitive hypertension.
    Zeng ZH; Luo BH; Gao YJ; Su CJ; He CC; Yi JJ; Li N; Lee RM
    Eur J Pharmacol; 2004 Oct; 503(1-3):129-33. PubMed ID: 15496307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of angiotensin II in early cardiovascular growth and vascular amplifier development in spontaneously hypertensive rats.
    Black MJ; Kanellakis P; Bobik A
    J Hypertens; 1997 Sep; 15(9):945-54. PubMed ID: 9321741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension.
    Thybo NK; Stephens N; Cooper A; Aalkjaer C; Heagerty AM; Mulvany MJ
    Hypertension; 1995 Apr; 25(4 Pt 1):474-81. PubMed ID: 7721386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of simvastatin given alone and in combination with valsartan or enalapril on blood pressure and the structure of mesenteric resistance arteries and the basilar artery in the genetically hypertensive rat model.
    Ledingham JM; Laverty R
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):76-85. PubMed ID: 15730439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP) and dual ACE/NEP inhibition on blood pressure and resistance arteries of deoxycorticosterone acetate-salt hypertensive rats.
    Pu Q; Touyz RM; Schiffrin EL
    J Hypertens; 2002 May; 20(5):899-907. PubMed ID: 12011651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Structural and functional changes of the microcirculation in hypertension: influence of pharmacological therapy].
    Agabiti-Rosei E
    Drugs; 2003; 63 Spec No 1():19-29. PubMed ID: 12708883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular wall thickness in hypertension: the Perindopril Regression of Vascular Thickening European Community Trial: PROTECT.
    Stumpe KO; Ludwig M; Heagerty AM; Kolloch RE; Mancia G; Safar M; Zanchetti A
    Am J Cardiol; 1995 Nov; 76(15):50E-54E. PubMed ID: 7484890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac hypertrophy and arterial compliance following drug treatment in hypertension.
    Asmar RG; Pannier BM; London GM; Safar ME
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S37-9. PubMed ID: 1725199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular remodeling: the role of angiotensin-converting enzyme inhibitors.
    Chrysant SG
    Am Heart J; 1998 Feb; 135(2 Pt 2):S21-30. PubMed ID: 9488609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardiac hypertrophy and arterial compliance after antihypertensive treatment].
    Asmar RG; Pannier BM; London GM; Safar ME
    Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():79-83. PubMed ID: 1838923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance vessel structure and the pathogenesis of hypertension.
    Mulvany MJ
    J Hypertens Suppl; 1993 Dec; 11(5):S7-12. PubMed ID: 8158439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.